granisetron and Neoplasm Metastasis

granisetron has been researched along with Neoplasm Metastasis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chow, E; DeAngelis, C; Hunyh, L; McDonald, R; Pasetka, M; Raman, S; Rowbottom, L1
Hosaka, M; Kondoh, K; Kubota, Y; Masuda, M; Misaki, H; Noguchi, S; Sakuramoto, T; Shuin, T; Yao, M1
Baron, PL; Cole, DJ; Maize, JC; McClay, EF; McClay, ME; Metcalf, JS; Monroe, L; O'Brien, PH1

Trials

2 trial(s) available for granisetron and Neoplasm Metastasis

ArticleYear
[M-VAC chemotherapy for advanced urothelial cancer--side effects and their management].
    Hinyokika kiyo. Acta urologica Japonica, 1994, Volume: 40, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Colony-Stimulating Factors; Doxorubicin; Female; Gastrointestinal Diseases; Granisetron; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neutropenia; Recombinant Proteins; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine

1994
The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.
    British journal of cancer, 2000, Volume: 83, Issue:1

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Granisetron; Humans; Life Tables; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Neoplasm Staging; Ondansetron; Prognosis; Risk; Skin Neoplasms; Survival Analysis; Tamoxifen; Treatment Outcome; Vomiting

2000

Other Studies

1 other study(ies) available for granisetron and Neoplasm Metastasis

ArticleYear
Efficacy of granisetron and aprepitant in a patient who failed ondansetron in the prophylaxis of radiation induced nausea and vomiting: a case report.
    Annals of palliative medicine, 2015, Volume: 4, Issue:1

    Topics: Antiemetics; Aprepitant; Bone Neoplasms; Breast Neoplasms; Female; Granisetron; Humans; Middle Aged; Morpholines; Nausea; Neoplasm Metastasis; Ondansetron

2015